Amantadine modulates action-specific neural ensembles in hypokinetic and hyperkinetic conditions
Preprint
Abstract
Background: In the classical model of basal ganglia circuitry, striatal spiny projection neurons of the direct and indirect pathways (dSPNs, iSPNs) promote and suppress movement, respectively, and exhibit unbalanced activity levels during hypokinetic or hyperkinetic conditions. Most therapies for these conditions are thought to work by rebalancing the relative activity of dSPNs and iSPNs towards normal levels. However, the mechanism of amantadine, which uniquely improves both hypokinetic and hyperkinetic conditions, is poorly understood. Objective: To determine whether amantadine restores motor function by normalizing the balance of dSPN and iSPN activity or through a distinct mechanism. Methods: We used dual-color two-photon Ca 2+ imaging in the 6-OHDA mouse model of Parkinson’s disease to concurrently monitor dSPN and iSPN dynamics across healthy, hypokinetic (parkinsonian), and hyperkinetic (dyskinetic) conditions. Results: We evaluated both dSPN/iSPN activity balance and action-specific neural ensemble activity in the dorsolateral striatum. In hypokinetic conditions, L-DOPA rescued the dSPN/iSPN imbalance but failed to restore the disrupted activity of the locomotion-specific ensemble. Conversely, amantadine improved locomotion-specific ensemble activity without normalizing the dSPN/iSPN imbalance. In hyperkinetic conditions, forelimb dyskinesias were characterized by neural activity patterns distinct from those encoding locomotion. Amantadine selectively suppressed the resting activity of forelimb dyskinesia ensembles without affecting locomotion-coding ensembles or restoring pathway balance. Conclusions: L-DOPA and amantadine may act through distinct mechanisms, with L-DOPA normalizing pathway balance and amantadine modulating action-specific neural ensembles. These findings support the importance of action-coding disruptions during hypokinetic and hyperkinetic conditions and suggest that correcting them can restore motor function.Keywords
Funding Information
- Stanford Knight Initiative for Brain Resilience
- Ludwig Family Foundation
- U.S. Department of War
This publication has 52 references indexed in Scilit:
- Complete representation of action space and value in all dorsal striatal pathwaysCell Reports, 2021
- Amantadine: reappraisal of the timeless diamond—target updates and novel therapeutic potentialsJournal of Neural Transmission, 2021
- Diagnosis and Treatment of Parkinson DiseaseJAMA, 2020
- Aberrant Striatal Activity in Parkinsonism and Levodopa-Induced DyskinesiaCell Reports, 2018
- Computational Methods Used in Hit-to-Lead and Lead Optimization Stages of Structure-Based Drug Discovery2017
- NoRMCorre: An online algorithm for piecewise rigid motion correction of calcium imaging dataJournal of Neuroscience Methods, 2017
- Complementary Contributions of Striatal Projection Pathways to Action Initiation and ExecutionCell, 2016
- Movement disorders2016
- Primate models of movement disorders of basal ganglia originTrends in Neurosciences, 1990
- The functional anatomy of basal ganglia disordersTrends in Neurosciences, 1989